News and Trends 5 May 2022 Amphista Lands Megadeals to Smash Cancer using Protein Degradation As big pharma companies flock to drugs that destroy harmful proteins, the UK protein degradation specialist Amphista Therapeutics has bagged two landmark collaboration deals with the heavyweights Bristol Myers Squibb and Merck. Big pharma companies are piling onto biotechs developing drugs that can cause the destruction of target proteins in the cell — a field […] May 5, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 3 May 2022 Tubulis Rides Investment Wave in ADCs with €60M Series B The German firm Tubulis has raised a €60M Series B round to advance cancer drugs called antibody-drug conjugates (ADCs) to clinical trials. This takes place as the ADC space is heating up with rapid approvals and investment deals. ADCs are the product of attempts to make more selective, safer versions of traditional chemotherapy. They consist […] May 3, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 2 May 2022 Chief Business Officers: Shedding Light on Biotech’s Dealmakers In addition to helping patients, biotech companies need to focus on the commercial potential of their work. Stephanie Bewick at Destiny Pharma outlines her experiences of how a Chief Business Officer maximizes their company’s commercial appeal and lands deals in the biotech industry. Stephanie Bewick began her career as an academic researcher before spending more […] May 2, 2022 - 5 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
News and Trends 29 Apr 2022 Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics The Danish National Genome Center has teamed up with the UK firm Lifebit to improve the access and sharing of genomic data as the nation moves towards the adoption of personalized medicine. Personalized medicine is capturing the attention of healthcare authorities across the world. By harvesting genome sequences from patient populations, researchers can mine vast […] April 29, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Apr 2022 OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll the development of small molecules against so-called ‘undruggable’ targets, including one that sank Quench Bio last year. In 2020, Quench Bio captured the imagination of investors with the US firm’s ambition to develop a new class of anti-inflammatory drugs. The […] April 28, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 27 Apr 2022 Cancer Research UK Deploys €700M to Foster Oncology Startups In a show of strength after an income squeeze during the Covid-19 pandemic, the charity Cancer Research UK has dedicated €711M (£600M) to setting up a new innovation arm and seed fund designed to speed up the commercialization of oncology innovation. For decades, Cancer Research UK (CRUK) has played a pivotal role in nurturing advances […] April 27, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 25 Apr 2022 Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The mission is to develop the first drugs to safeguard heart muscle from damage during heart attacks. A sudden heart attack, also known as acute myocardial infarction, happens when the flow of blood to the heart […] April 25, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Opinion 25 Apr 2022 Cloud Computing Can Help Life Sciences Catch Up Before It’s Too Late Biotechnology has the power to tackle global threats such as pandemics and climate change, but antiquated experimental and data collection methods are holding it back. Guy Levy-Yurista, CEO of the experiment platform developer Synthace, explains how cloud computing could accelerate the efforts of biotech companies to solve the big problems. There is a sundial in […] April 25, 2022 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 22 Apr 2022 European Biotech Investors Brace for Volatility in 2022 After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with the plan to steadily fund private biotechs amid a tumultuous public market. The last two years have seen a record-breaking amount of money flowing to biotech investors, with almost €10B reaching European life science funders […] April 22, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Apr 2022 Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights A Covid-19 vaccine developed by the French company Valneva has received the green light from the UK’s drug regulator. The EMA, meanwhile, is proving harder to convince. The UK’s relationship with the French vaccine developer Valneva has run hot and cold over the past two years. In 2020, the UK government invested in Valneva’s manufacturing […] April 20, 2022 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 19 Apr 2022 How Augmented Reality Strengthens Biotech Manufacturing Biotech and pharma companies are starting to implement augmented reality technologies at their manufacturing facilities, bringing forth a whole new world of possibilities. The Covid-19 pandemic has been a catalyst for embracing new ways of working. Travel restrictions and limited access to facilities have pushed the adoption of technologies that enhance remote work. This is […] April 19, 2022 - 8 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
In Depth 13 Apr 2022 Cultured Meat Is Coming Soon: Here’s What You Need to Know Cultured meat promises to change the way we eat and help solve some of the big problems of a crowded planet. When will it be on our plate and how will this technology impact the world? In a couple of years, your food might be served with meat that has been grown from animal cells […] April 13, 2022 - 12 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email